Purple Biotech Ltd. (TASE:PPBT) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Gagnon Other companies: Opus Genetics, Inc. (Chief Financial Officer · Since at least Sep 2, 2025); Bone Biologics Corp (Director · Since at least Jan 8, 2024); Verastem, Inc. (Director · Since at least Aug 28, 2018); Harvard Bioscience, Inc. (Director · Since at least Nov 18, 2013); Clean Harbors, Inc. (EVP CFO and Treasurer · Aug 20, 2012 – Sep 11, 2012 · Past); Biogen Inc. (Vice President, Finance · Nov 3, 2010 – Feb 28, 2012 · Past) | Board Member · Since at least Mar 18, 2026 |
| Eric K. Rowinsky Other companies: Verastem, Inc. (Director · Since at least Jun 21, 2019); Biogen Inc. (Director · Since at least Jun 19, 2019); Fortress Biotech, Inc. (Director · Jan 1, 2019 – Jan 1, 2024 · Past) | Chairman of the Board · Since at least Mar 13, 2026 |
| Gil Efron | Executive Director, Head of Corporate Development · Until Mar 13, 2026 · Past |
| Gil Efron | Chief Executive Officer · Since at least Mar 18, 2026 |
| Hadas Reuveni | Vice President Research & Development · Since at least Dec 11, 2025 |
| Ido Agmon | Board Member · Since at least Mar 18, 2026 |
| Isaac Israel | Interim Chief Executive Officer · Since at least Nov 6, 2026 |
| Michael Schickler | Head of Clinical and Regulatory Affairs · Since at least Oct 29, 2025 |
| Shai Lankry | Chief Financial Officer · Since at least May 12, 2025 |
| Simcha Rock | Director · Since at least Mar 18, 2026 |
| Suzana Nahum-Zilberberg | Board Member · Since at least Mar 18, 2026 |
| Yael Margolin | Board Member · Since at least Nov 6, 2026 |